CWCA (ABWM): A Stalled Venous Ulcer: Biofilm Versus Spreading Infection

Interpretation: this picture - a friable, shiny, easily bleeding film, increased serous drainage, new dull pain, and stalled healing, without spreading erythema, warmth, purulence, or systemic signs - is consistent with biofilm and critical colonization, not invasive infection. The normal WBC supports that reading.

What I will do:

• Cleanse and debride to disrupt the biofilm physically. Thorough cleansing with a surfactant wound cleanser, then mechanical or conservative sharp debridement of the film back to a clean bleeding base. Biofilm re-forms within roughly 24-72 hours, so debridement must be repeated on a schedule, not done once.
• Manage moisture. Moderate exudate with fragile periwound skin: a foam, hydrofiber, or gelling fiber to control exudate, plus a barrier film on the peri-wound.
• Consider a topical antimicrobial for a defined trial period (e.g., silver, PHMB, cadexomer iodine, or medical-grade honey) for roughly 2 weeks, with a documented start date and a scheduled re-evaluation of whether it is helping. Topical agents treat the wound surface; they do not treat cellulitis.
• Optimize compression. "Most days" is the likely root cause of the stall - confirm the regimen, the measurement, the donning technique, and whether pain is limiting wear. Compression is the intervention that closes venous ulcers.

What I will not do:

• I will not start systemic antibiotics for colonization - this drives resistance and does not remove biofilm.
• I will not send a superficial swab. Swabs grow colonizers, not pathogens, and will trigger unnecessary treatment.
• I will not keep the same dressing for another month without a documented reassessment date.

This is now a spreading soft tissue infection (cellulitis) with systemic signs - the management changes from topical to systemic.

Immediate actions:

• Obtain a specimen correctly. After cleansing and debriding the wound base, obtain a tissue specimen - punch biopsy or curettage of the wound base - which is far more reliable than a superficial swab. If tissue sampling is not feasible, use the Levine technique (rotate a swab with sufficient pressure over a 1 cm2 area of viable tissue) and interpret cautiously. Blood cultures if the patient is systemically unwell.
• Mark the border of erythema with a pen and date/time it, so response can be judged objectively in 24 hours rather than from memory.
• Start empiric systemic antibiotics directed by local antibiogram and patient factors (allergy, renal function, recent antibiotics, MRSA risk), then narrow to culture results. Notify the prescriber now; do not wait for the culture.
• Assess for deeper involvement. Probe for bone; an ulcer present for weeks with new infection raises osteomyelitis risk - plain films and, if suspicion persists, MRI. Consider hospitalization if she is systemically ill, unable to take oral antibiotics, or has rapid progression.
• Address glucose - hyperglycemia worsens infection and healing; coordinate with the PCP.
• Wound care continues (cleansing, debridement of slough, exudate management, periwound protection). Whether to continue compression during active infection is a judgment call: hold or reduce if it worsens pain or if infection is uncontrolled, but compression is generally not contraindicated in venous disease with an ABI of 1.0 once infection is being treated.

Teaching point: topical antiseptics do not penetrate to treat cellulitis. Once erythema extends beyond the wound margin with warmth and systemic signs, systemic therapy is mandatory.

Document (objective, timed, comparable):

• Wound description: size with method, tissue types as percentages, exudate amount/color/odor, periwound erythema measured in cm from the wound edge with the border marked, warmth, tenderness, probe-to-bone result.
• Vital signs, glucose, and relevant labs, with times.
• The specimen type obtained, who obtained it, and when results are expected.
• The antibiotic start date, agent, and the plan to review and narrow at 48-72 hours.
• The reassessment interval (e.g., "recheck erythema border and temperature in 24 hours") and the escalation criteria.
• Patient education given: signs to report immediately (spreading redness, fever, worsening pain, foul drainage).

Communicate: use a structured SBAR handoff to the prescriber and the oncoming nurse - Situation (new spreading erythema, fever 38.3), Background (6-month venous ulcer, prior biofilm management), Assessment (suspect cellulitis, culture pending, glucose 288), Recommendation (antibiotics, border marking, 24-hour recheck, consider imaging for osteomyelitis). Share the plan change with the wound team and the aide doing the dressing changes, and make sure the order set matches what is actually being done.

Why the distinction matters: treating colonization with systemic antibiotics selects for resistant organisms, exposes the patient to unnecessary adverse effects including C. difficile, and does nothing about the actual problem - biofilm. Conversely, under-calling a spreading infection risks sepsis, amputation, and, in this patient, loss of the limb. The clinical skill being tested is recognizing the shift from a surface problem to an invasive one and matching the intervention to the level of invasion.